✦ LIBER ✦

Paclitaxel Drug-Coated Balloons: A Review of Current Status and Emerging Applications in Native Coronary Artery De Novo Lesions

✍ Scribed by Joshua P. Loh; Ron Waksman

Book ID: 119289572
Publisher: American College of Cardiology
Year: 2012
Tongue: English
Weight: 411 KB
Volume: 5
Category: Article
ISSN: 1936-8798
DOI: 10.1016/j.jcin.2012.08.005

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparison of Everolimus-Eluting and Pac

Comparison of Everolimus-Eluting and Paclitaxel-Eluting Coronary Stents in Patients Undergoing Multilesion and Multivessel Intervention: The SPIRIT III (A Clinical Evaluation of the Investigational Device XIENCE V Everolimus Eluting Coronary Stent System [EECSS] in the Treatment of Subjects With De Novo Native Coronary Artery Lesions) and SPIRIT IV (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System in the Treatment of Subjects With De Novo Native Coronary Artery Lesions) Randomized Trials

✍ Dean J. Kereiakes; Krishnankutty Sudhir; James B. Hermiller; Paul C. Gordon; Joa 📂 Article 📅 2010 🏛 American College of Cardiology 🌐 English ⚖ 939 KB

Safety and efficacy of low-dose paclitax

Safety and efficacy of low-dose paclitaxel utilizing the cobra-P drug-eluting stent system with a novel biodegradable coating in de novo coronary lesions: The PLUS-ONE first-in-man study

✍ Calderas, Carlos; Condado, Jose Francisco; Condado, Jose Antonio; Flores, Alejan 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 509 KB

TCT-267: The PLUS-ONE First-in-Man (FIM)

TCT-267: The PLUS-ONE First-in-Man (FIM) Study: Safety and Efficacy of Low-Dose Paclitaxel and the COBRA-P Drug-Eluting Stent System with a Novel Biodegradable Coating in de novo Coronary Lesions

📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 137 KB

Late-Term Clinical Outcomes With Zotarol

Late-Term Clinical Outcomes With Zotarolimus- and Sirolimus-Eluting Stents: 5-Year Follow-Up of the ENDEAVOR III (A Randomized Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Cypher Sirolimus-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions)

✍ David E. Kandzari; Laura Mauri; Jeffrey J. Popma; Mark A. Turco; Paul A. Gurbel; 📂 Article 📅 2011 🏛 American College of Cardiology 🌐 English ⚖ 704 KB

Long-Term Clinical and Economic Analysis

Long-Term Clinical and Economic Analysis of the Endeavor Drug-Eluting Stent Versus the Driver Bare-Metal Stent: 4-Year Results From the ENDEAVOR II Trial (Randomized Controlled Trial to Evaluate the Safety and Efficacy of the Medtronic AVE ABT-578 Eluting Driver Coronary Stent in De Novo Native Coronary Artery Lesions)

✍ Eric L. Eisenstein; William Wijns; Jean Fajadet; Laura Mauri; Rex Edwards; Patri 📂 Article 📅 2009 🏛 American College of Cardiology 🌐 English ⚖ 364 KB